Post-earnings recap
Reported
Tue, Nov 6, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corporation's earnings report showed a slight miss on EPS, which may raise concerns among some investors. However, the stock reacted positively, increasing by 3.19%. This uptick could indicate investor confidence in the company's long-term strategy, despite the EPS miss.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.56 | N/A | -2.80% |
Overall, management conveyed a cautiously optimistic outlook, focusing on operational improvements. They acknowledged challenges but emphasized their commitment to long-term growth.
Management highlighted ongoing efforts to improve operational efficiencies.
They expressed confidence in long-term growth despite current challenges.